Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sodium taurocholate (Taurocholate Sodium) hydrate is the main end product of cholesterol catabolism. During enterohepatic circulation, bile taurocholic acid is converted by the microorganisms to taurodeoxycholic acid and deoxycholic acid.[3] These are reabsorbed by the liver via a carrier-mediated process and converted by liver enzymes to taurocholic acid.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 mg | In stock | $ 50.00 | |
1 g | In stock | $ 64.00 | |
5 g | In stock | $ 105.00 |
Description | Sodium taurocholate (Taurocholate Sodium) hydrate is the main end product of cholesterol catabolism. During enterohepatic circulation, bile taurocholic acid is converted by the microorganisms to taurodeoxycholic acid and deoxycholic acid.[3] These are reabsorbed by the liver via a carrier-mediated process and converted by liver enzymes to taurocholic acid. |
Synonyms | Taurocholate Sodium |
Molecular Weight | 538.69 |
Formula | C26H45NO7S.Na |
CAS No. | 145-42-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (111.59 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Sodium taurocholate 145-42-6 Others I nterleukin-1β Tumor necrosis factor-α inhibit Sodium taurocholate hydrate Immunoregulation VEGFR Taurocholic acid N-Choloyltaurine Taurocholate Sodium VEGF-A expression Vascular endothelial growth factor receptor Endogenous Metabolite CD4+/CD8+ hepatic artery Inhibitor inhibitor